PARAGANGLION NEOPLASM

This adverse event was reported 146 times

PARAGANGLION NEOPLASM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 METYROSINE 2 0.0247
1 LUTETIUM LU 177 DOTATATE 9 0.0015
2 FINGOLIMOD HYDROCHLORIDE 4 0.0008
3 ELOTUZUMAB 2 0.0004
4 AZILSARTAN KAMEDOXOMIL 1 0.0003
5 PRAZOSIN 2 0.0003
6 ELAGOLIX 1 0.0003
7 LABETALOL 3 0.0002
8 CHLORTHALIDONE 2 0.0002
9 DOXEPIN HYDROCHLORIDE 2 0.0002
See all drugs enriched for association with PARAGANGLION NEOPLASM